Moderna Price Target Raised To $139 From $107 At Goldman Sachs
November 25, 2020 at 07:19 AM EST
Goldman Sachs analyst Salveen Richter raised the firm's price target on Moderna to $139 from $107 and keeps a Buy rating on the shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|